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Disinfection by-products (DBPs) are formed
when organic and inorganic matter react with
disinfectants used to treat drinking water.
Some DBPs are known reproductive and
developmental toxins. Teratogenicity has
been reported in animals exposed to halo-
acetic acids (HAAs) (Epstein et al. 1992;
Smith et al. 1989a, 1992) and haloacetoni-
triles (Smith et al. 1988, 1989b), and there is
evidence that 3-chloro-4-(dichloromethyl)-
5-hydroxy-2(5H)-furanone (MX) may be a
direct-acting teratogen in vitro (Teramoto
et al. 1998). The trihalomethanes (THMs)
are not considered teratogenic, but growth
retardation has been reported in mice exposed
to chloroform (Murray et al. 1979; Ruddick
et al. 1983; Schwetz et al. 1974; Thompson
et al. 1974). Growth retardation has also been
reported in mice exposed to dichloroacetic
acid (Smith et al. 1992) and trichloroacetic
acid (Smith et al. 1989a) and in rats exposed
to dichloroacetonitrile (Smith et al. 1989b)
and trichloroacetonitrile (Smith et al. 1987).
Epidemiologic data suggest an association
between DBPs and adverse developmental
outcomes (Graves et al. 2001; Nieuwenhuijsen
et al. 2000; Reif et al. 1996). Bove et al. (1995)
observed a 42% increased risk of low birth
weight associated with total THM (TTHM)
concentrations > 100 µg/L compared with
those ≤ 20 µg/L. Savitz et al. (1995) reported a
30% increased risk of low birth weight for
TTHM exposures ≥ 82.8 µg/L compared with
those < 40.8 µg/L but found no effect for
maternal dose estimated from TTHM con-
centration and the number of glasses of water
consumed per day. Gallagher et al. (1998)
reported associations between > 60 µg/L
TTHM (vs. ≤ 20 µg/L) and low birth weight
in term births [odds ratio (OR) = 5.9; 95%
conﬁdence interval (CI), 2.0 to 17.0] and all
births (OR = 2.1; 95% CI, 1.0 to 4.8). Wright
et al. (2003) found an increased risk of infants’
being small for gestational age (SGA) associ-
ated with TTHM concentrations > 80 µgL
(OR = 1.14; 95% CI, 1.02 to 1.26) compared
with ≤ 60 µg/L. A 50% increased risk of SGA
was reported by Bove et al. (1995) for TTHM
concentrations > 100 µg/L (OR = 1.50; 95%
CI, 1.14 to 1.94) compared with ≤ 20 µg/L.
An 8% increased risk (OR = 1.08; 95% CI,
0.99 to 1.18) of SGA was reported by Dodds
et al. (1999) for TTHM ≥ 100 µg/L compared
with < 50 µg/L. No associations between
preterm delivery and DBP concentrations have
been reported (Bove et al. 1995; Dodds et al.
1999; Gallagher et al. 1998; Kramer et al.
1992; Savitz et al. 1995; Wright et al. 2003).
TTHM concentration is the most common
surrogate of DBP exposure used in epidemio-
logic studies, but independent effects of indi-
vidual THMs have been reported. Waller et al.
(1998) found an increased risk of spontaneous
abortions in women drinking five or more
glasses per day of cold tap water containing
≥ 75 µg/L TTHM (OR = 1.8; 95% CI, 1.1 to
3.0) and ≥ 18 µg/L bromodichloromethane
(BDCM; OR = 3.0; 95% CI, 1.4 to 6.6). King
et al. (2000) detected a 98% (OR = 1.98; 95%
CI, 1.23 to 3.49) increased risk for stillbirths
among mothers exposed to ≥ 20 µg/L BDCM
(vs. < 5 µg/L) and a 66% increased risk (OR =
1.66; 95% CI, 1.09 to 2.54) for TTHM
≥ 100 µg/L (vs. < 50 µg/L). Few epidemiologic
studies have evaluated the impact of non-
volatile DBPs on fetal development. Kramer
et al. (1992) examined the impact of total
organic halides but reported difﬁculty distin-
guishing between the effects of this surrogate
with highly correlated DBPs. The relation-
ship between fetal development outcomes
and individual nonvolatile DBPs has not
been examined, but these DBPs are likely
even less correlated with TTHM concentra-
tions (Wright et al. 2002). We previously
detected high levels of MX and mutagenic
activity in drinking water from Massachusetts
(Wright et al. 2002), as well as associations
between TTHM and different fetal develop-
ment indices (Wright et al. 2003). In the pre-
sent study, we used several years of birth
certificate data to examine the relationship
between indices of fetal development and var-
ious town average exposure metrics. Exposure
measures included previously collected MX and
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Epidemiologic studies of disinfection by-products have traditionally focused on total trihalomethane
(TTHM) concentration as a surrogate for maternal exposure during pregnancy. We used birth certiﬁ-
cate data on 196,000 infants to examine the effect of third-trimester exposures on various indices of
fetal development. We examined the effect of town-average concentrations of TTHM and additional
exposure metrics in relation to mean birth weight, mean gestational age, small for gestational age
(SGA) infancy, and preterm delivery. Trihalomethane data (TTHM, chloroform, and bromo-
dichloromethane) from 1995–1998 were available for 109 towns in Massachusetts. Data from
1997–1998 on haloacetic acid (total haloacetic acids, dichloroacetic acid, and trichloroacetic acid),
3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), and mutagenicity were available for a
limited number of towns. We observed reductions in mean birth weight (12–18 g) for maternal tri-
halomethane exposures > the 90th percentile compared with those < the 50th percentile. Birth weight
reductions were detected for chloroform exposures > 20 µg/L and TTHM exposures > 40 µg/L.
Elevated trihalomethanes were associated with increases in gestational duration and a reduced risk of
preterm delivery. We found evidence of an exposure–response effect of trihalomethanes on risk of
SGA, with odds ratios (ORs) ranging from 1.09 to 1.23 for bromodichloromethane exposures
>5µ g/L. Elevated mutagenic activity was associated with SGA [OR = 1.25; 95% conﬁdence interval
(CI), 1.04 to 1.51] and mean birth weight (–27 g; 95% CI, –54 to –1). Although smaller in magni-
tude, our ﬁndings are consistent with previous studies reporting associations between trihalomethanes
and SGA. These data also suggest a relationship between fetal development indices and mutagenic
activity independent of exposure to trihalomethanes, haloacetic acids, and MX. Key words: birth
weight, bromodichloromethane, chloroform, gestational age, haloacetic acids, mutagenic activity, MX,
preterm delivery, small for gestational age, trihalomethanes. Environ Health Perspect 112:920–925
(2004). doi:10.1289/ehp.6779 available via http://dx.doi.org/ [Online 18 February 2004]mutagenicity data, as well as TTHM, BDCM,
chloroform, total HAA, dichloroacetic acid,
and trichloroacetic acid concentrations.
Materials and Methods
Study population. The Massachusetts
Department of Public Health (Boston, MA)
supplied 1995–1998 birth certificate data
(n = 282,645) for towns with populations
> 10,000. These data contained detailed mater-
nal and infant information including birth
weight and gestational age. We excluded
infants with implausible values for birth weight
(< 200 g) and gestational age (< 22 or > 45
weeks) and those born to nonresidents. The
remaining birth data were linked with drinking
water DBP and mutagenicity measurements to
examine the effect of maternal third-trimester
exposure on mean birth weight and SGA in
term births and preterm delivery and mean
gestational age in all births.
Outcome data. Gestational age recorded
on the birth certiﬁcates was based on clinician
estimate. SGA infancy was deﬁned as the low-
est decile of birth weight for each gestational
week stratified by infant sex and maternal
race. We restricted the SGA and birth weight
analyses to term births from 37–45 gesta-
tional weeks. Preterm delivery was deﬁned as
< 37 gestational weeks, whereas very preterm
was defined as < 34 weeks. Infants at least
37 gestational weeks and weighing at least
2,500 g served as the comparison group for
the estimated ORs.
Exposure data. We used town-specific
aggregate data to estimate maternal exposure to
THMs, HAAs, MX, and mutagenic activity in
drinking water. We abstracted 1995–1998
THM data from the Massachusetts Department
of Environmental Protection (Boston, MA)
records. Community systems that use disin-
fectants and serve populations > 10,000 were
required to monitor THMs on a quarterly
basis. Of the 109 towns with THM data, nine
towns were granted waivers allowing annual
monitoring. The THM samples collected by
each town were analyzed by laboratories certi-
fied by the U.S. Environmental Protection
Agency (EPA) or the Massachusetts Depart-
ment of Environmental Protection, by means
of gas chromatography (U.S. EPA method
502.2) and gas chromatography/mass spec-
trometry (U.S. EPA Method 524.2; U.S. EPA
1995). TTHM concentration was deﬁned as
the sum of chloroform, BDCM, dibromo-
chloromethane, and bromoform. Dibromo-
chloromethane and bromoform rarely
exceeded the detection limit in these sampled
communities, so we restricted the data analysis
to chloroform, BDCM, and TTHM.
HAA samples were collected by 17 towns
on a weekly to quarterly basis from 1997 to
1998 and were analyzed using gas chromatogra-
phy (U.S. EPA method 552; U.S. EPA 1995).
Total HAAs included monochloroacetic,
dichloroacetic, trichloroacetic, monobromo-
acetic, and dibromoacetic acids. Monochloro-
acetic acid, monobromoacetic acid, and
dibromoacetic acid rarely exceeded the detec-
tion limit in these sampled communities, so
we restricted the data analysis to dichloroacetic
acid, trichloroacetic acid, and total HAAs.
We previously measured MX and muta-
genic activity in Massachusetts’ surface water
systems described in detail elsewhere (Wright
et al. 2002). Brieﬂy, we collected 88 tap water
samples from 36 towns during the fall and
spring of 1997 and 1998. The tap water sam-
ples were collected in 4-L bottles, extracted,
and evaporated to 1 mL ethyl acetate. The
extracts were analyzed at the Laboratory of
Chemistry of the National Public Health
Institute in Kuopio, Finland. MX concentra-
tions were measured using gas chromatography/
mass spectroscopy (Fawell and Horth 1990).
Mutagenicity, measured as the number of net
revertants (rev) per liter, was determined by
the plate incorporation method of Maron and
Ames (1983). The Ames test was conducted
on Salmonella typhimurium tester strain
TA100, which has been shown to be the most
sensitive strain for detecting mutagenicity
caused by MX (Daniel et al. 1991). MX is a
direct-acting mutagen, so no metabolic acti-
vation was required. After linkage with the
birth certificate data, MX and mutagenicity
measurements for 34 towns were available for
use in the present study.
Exposure assessment. Maternal ZIP code
and infant month of birth were used to assign
third-trimester town-speciﬁc DBP and muta-
genicity data. Quarterly town averages were
calculated from all available samples for the dif-
ferent sampling locations. Towns with annual
THM measurements were assigned the same
concentration for each quarter. To estimate
third-trimester exposures, each mother with an
infant born in the second or third month of a
quarter was assigned the mean quarterly value
for her town of residence. For infants born in
the ﬁrst month of a quarter, the third-trimester
exposure was determined from the previous
quarterly average concentration. Mothers deliv-
ering before 29 gestational weeks were not
assigned a third-trimester value. We divided
maternal exposures into approximately the
lowest 50th percentile (reference), 50th–90th
percentile, and > the 90th percentile. We also
examined exposure–response gradients based
on equal increments of THM concentration.
Statistical methods. Statistical Analysis
Systems software (SAS, version 6.11; SAS
Institute, Inc., Cary, NC) was used for the sta-
tistical analyses. We used linear regression to
estimate changes in birth weight and gestational
age associated with exposure to DBPs and
mutagenic activity. We used logistic regression
to estimate ORs for preterm delivery and SGA
infancy. To indicate the precision of the effect
estimates, 95% CIs were calculated. Pearson
correlation coefﬁcients were used to examine
the relation between the town-speciﬁc exposure
metrics. We included the categorical THM
variables as continuous regressors in the ﬁnal
models as a test of trend for the exposure–
response analyses.
The regression models were adjusted for
the following dichotomous maternal risk fac-
tors: diabetes, lung disease, renal disease,
chronic hypertension, marital status, previous
preterm delivery, and previous birth to an
infant weighing > 4,000 g. We also included
categorical variables for maternal education,
parity, prenatal care, and the number of ciga-
rettes smoked per day based on a previous
analysis of nonparametric smooth functions
(Hattis D. et al., unpublished data). The ade-
quacy of prenatal care classiﬁcation (no care,
inadequate care, intermediate care, and ade-
quate) was based on the Kessner index, which
incorporates gestational age, timing of the
first prenatal visit, and total number of pre-
natal visits (Alexander and Kotelchuck 1996).
A quadratic polynomial for maternal age
and categorical variables for maternal race
(Caucasian, African American, Asian, Native
American, and other) were included in all of
the regression models. Except for the SGA
analyses, all of the regression models were
adjusted for infant sex. Median household
incomes specific to ZIP code obtained from
1990 U.S. Census data (Geolytics, Inc., East
Brunswick, NJ) and weight gain during preg-
nancy were included as continuous variables.
Weight gain during pregnancy and marital
status were not available on birth certiﬁcates
before 1997, so we could not adjust for these
covariates in the THM analyses.
Results
As shown in Table 1, the study population
included Massachusetts residents with singleton
infants 22–45 gestational weeks and ≥ 200 g
(n = 196,000). Of the 194,827 births with
recorded gestational age and THM measure-
ments, 11,580 (6%) were classiﬁed as preterm
deliveries (< 37 gestational weeks). Among the
183,247 term births, 17,359 (9%) were classi-
ﬁed as SGA. Prenatal care and maternal smok-
ing were the strongest risk factors for the three
outcomes. Mothers without prenatal care had
infants that weighed an average of 250 g less
than those with adequate prenatal care. Similar
reductions in infant birth weight were observed
among mothers smoking > 10 cigarettes per day
compared with nonsmokers. Third-trimester
TTHM exposure was weakly associated with
mean birth weight and SGA infancy in these
unadjusted analyses.
Table 2 shows the distribution of third-
trimester DBP and mutagenic activity exposure
for residents of towns with populations
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exposure was 38 µg/L, with 7% of the mater-
nal exposures exceeding 80 µg/L. The maxi-
mum total HAA concentration was 58 µg/L,
and the average maternal exposure was 31
µg/L. The average third-trimester exposure
was 25 ng/L for MX and 1,400 rev/L for
mutagenicity.
Birth weight. Reductions in mean birth
weight were observed for individual THMs,
MX, and mutagenic activity (Table 3).
Compared with TTHM levels < 50th per-
centile (≤ 33 µg/L), exposures in the 50th–90th
percentiles (> 33 to 74 µg/L) and those > 90th
percentile (> 74 µg/L) were associated with
12-g (95% CI, –16 to –7) and 18-g (95% CI,
–26 to –10) reductions in birth weight, respec-
tively. Similar associations were observed for
chloroform, whereas smaller effects were
observed for BDCM. Statistically significant
tests for trend (p < 0.001) were detected sug-
gesting an exposure–response relationship
between birth weight and THM exposures.
Although a monotonic gradient was not evi-
dent for any of the THM exposure metrics
(Figure 1), reductions in mean birth weight
were observed for chloroform concentrations
> 20 µg/L and TTHM exposures > 40 µg/L.
The number of towns with MX, mutagenic-
ity, and HAA data was limited. Nevertheless,
exposure to high MX concentrations resulted
in mean birth weight reductions similar to
those observed for THMs (Table 3). Elevated
mutagenicity (> 2,250 rev/L) was associated
with a 27-g (95% CI, –54 to –1) reduction
compared with the reference population
(≤ 1,250 rev/L). No associations were
detected for high third-trimester HAA expo-
sures, but birth weight increases > 20 g were
observed for intermediate total haloacetic and
trichloroacetic acids.
Gestational age. We detected an associa-
tion between mean gestational age and expo-
sure to THMs and mutagenicity (Table 3).
Mothers exposed to high THM concentrations
had slightly longer gestational periods (0.4–0.5
days) than did those with lower exposures.
Mutagenicity > 2,250 rev/L was associated
with longer gestation (1.1 days; 95% CI,
0.4 to 1.7) compared with ≤ 1,250 rev/L.
Trichloroacetic acid > 27 µg/L was associated
with shorter gestational duration (–0.9 days;
95% CI, –1.7 to –0.1) compared with
≤ 18 µg/L.
SGA births. Statistically signiﬁcant tests for
trend (p ≤ 0.002) suggested an exposure–
response relationship between SGA and categor-
ical THM exposures. We detected a monotonic
increase in risk of SGA for chloroform exposures
> 20 µg/L (Figure 2). A monotonic gradient was
not evident between SGA and BDCM, but
associations were detected for exposures
>5µ g/L (ORs = 1.09–1.23). We found similar
ORs (1.05–1.15) for intermediate and high
THM exposures based on the 50th and 90th
percentile cut points (Table 4). Relative risks
similar in magnitude were observed for elevated
exposures to MX (OR = 1.14; 95% CI, 0.95 to
1.37) and mutagenic activity (OR = 1.25;
95% CI, 1.04 to 1.51). We did not detect an
increased risk of SGA infancy for high HAA
exposures, but inverse associations were
detected for intermediate trichloroacetic and
dichloroacetic acid exposures.
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Table 1. Characteristics of singleton infants born 1995–1998 in Massachusetts towns with populations >
10,000 with TTHM data available.
Study Mean birth Preterm
Characteristics population [no. (%)] weight (g)a SGA (%)a,b delivery (%)c
Total births (no.) 196,000 3,463 17,359d 11,580d
Maternal race
Caucasian 138,381 (70.8) 3,509 8.5 5.5
African American 19,213 (9.8) 3,346 9.8 11.0
Other 27,106 (13.9) 3,370 12.6 8.7
Asian 10,357 (5.3) 3,283 15.4 7.1
American Indian 360 (0.2) 3,434 10.6 9.0
Maternal age [years]
12–20 24,794 (12.7) 3,322 14.2 9.1
21–25 36,093 (18.4) 3,409 11.2 6.8
26–30 56,799 (29.0) 3,481 8.7 5.9
31–35 54,094 (27.6) 3,520 7.6 5.7
36–40 21,234 (10.8) 3,514 8.2 6.8
41–53 2,984 (1.5) 3,484 10.5 8.3
Maternal education
≤ 9th grade 14,743 (7.6) 3,329 14.8 9.8
10th grade 9,192 (4.7) 3,333 14.0 8.8
11th grade 10,536 (5.4) 3,345 13.7 8.8
High school graduate 160,649 (82.3) 3,489 8.5 6.0
Maternal smoking (cigarettes/day)
0 168,463 (86.3) 3,491 8.2 6.1
1–5 8,711 (4.5) 3,323 15.1 8.7
6–10 10,134 (5.2) 3,271 17.9 9.1
> 10 7,888 (4.0) 3,238 20.7 10.2
Prenatal care (Kessner index)
No prenatal care 464 (0.2) 3,233 19.9 25.1
Inadequate 6,582 (3.4) 3,333 14.1 10.6
Intermediate 33,860 (17.5) 3,399 11.5 9.1
Adequate 152,305 (78.8) 3,483 8.8 5.7
No. of previous births
0 87,278 (44.5) 3,412 11.6 7.3
1 64,149 (32.7) 3,508 7.5 5.3
2 or 3 38,878 (19.8) 3,502 8.2 6.4
≥ 4 5,636 (2.9) 3,450 10.1 10.1
Infant sex
Male 100,428 (51.2) 3,525 9.3 6.9
Female 95,572 (48.8) 3,398 9.7 6.2
Third-trimester TTHM (µg/L)
0–20 63,138 (32.2) 3,484 8.6 6.7
> 20–40 48,623 (24.8) 3,468 9.3 6.5
> 40–60 44,218 (22.6) 3,442 10.3 6.6
> 60–80 25,562 (13.0) 3,440 10.2 6.6
> 80–163 14,459 (7.4) 3,454 10.5 5.8
aInfants 22–45 gestational weeks and ≥ 200 g. bSGA deﬁned as lowest 10% of birth weight per gestational age, sex, and race.
cInfants < 37 gestational weeks and ≥ 200 g. dAmong 194,827 infants with recorded clinical estimates of gestational age.
Table 2. Maternal third-trimester exposure to DBPs and mutagenic activity for residents of Massachusetts
towns with populations > 10,000 during 1995–1998.
No. of No. of
towns births 10tha Median 90tha Maximum Mean ± SD
THMs (µg/L)b
TTHM 109 196,000 8 33 74 163 38.2 ± 27.0
Chloroform 109 195,506 4 25 63 135 31.0 ± 23.6
BDCM 109 195,506 1 4 12 46 5.7 ± 5.1
HAAs (µg/L)c
Total HAAs 17 18,750 13 30 49 58 31.4 ± 13.6
Trichloroacetic acid 15 14,151 9 19 28 37 16.9 ± 7.5
Dichloroacetic acid 15 14,151 8 15 24 24 15.3 ± 5.7
MX (ng/L)c 34 16,378 13 20 45 80 24.6 ± 12.8
Mutagenicity (rev/L)c 34 16,378 820 1,260 2,040 5,710 1,410 ± 700
aPercentile. b1995–1998 data. c1997–1998 data.Preterm delivery. The risk of preterm deliv-
ery (< 37 gestational weeks) was signiﬁcantly
lower for mothers with intermediate and high
THM exposures (ORs = 0.88–0.95; Table 4).
Elevated levels of HAAs, MX, and mutagenicity
were not associated with preterm delivery. No
associations were detected between very
preterm infants (< 34 gestational weeks) and
THMs, MX, mutagenicity, or dichloroacetic
acid (data not shown), but an increased risk was
observed for high trichloroacetic (OR = 1.33;
95% CI, 0.77 to 2.30) and total HAAs (OR =
1.48; 95% CI, 0.84 to 2.61).
Discussion
Low birth weight and preterm delivery are
strongly associated with infant morbidity and
mortality (Branum and Schoendorf 2002;
Infant Health and Development Program
1990; McCormick 1985), especially in the
United States, where infant mortality rates
are largely attributable to preterm delivery
(Wilcox et al. 1995). Although many impor-
tant risk factors have been identified, the
underlying etiology of approximately 60% of
preterm deliveries and 40% of low-birth-
weight infants remains unclear (Wollmann
1998). There is increasing interest in the role
of environmental exposures, including ambi-
ent air pollution (Bobak 2000; Maisonet et al.
2001; Ritz and Yu 1999; Rogers et al. 2000;
Wang et al. 1997) and DBPs in drinking
water (Graves et al. 2001; Nieuwenhuijsen
et al. 2000; Reif et al. 1996).
Consistent with previous term birth analy-
ses (Bove et al. 1995), we found associations
between TTHM exposures > 40 µg/L and
mean birth weight. Reductions in birth weight
were also observed for low third-trimester chlo-
roform (> 20 µg/L) and BDCM (> 5 µg/L)
concentrations. Exposure to high levels of
mutagenic activity resulted in the largest reduc-
tion in birth weight (–27 g; 95% CI, –54 to
–1). The reductions in mean birth weight asso-
ciated with DBPs and mutagenicity were an
order of magnitude less than those observed for
maternal smoking and other risk factors.
We evaluated SGA infancy as a measure of
fetal growth restriction, because birth weight is
a function of gestational duration and rate of
fetal growth. We found evidence of exposure–
response effects of THMs on SGA and a
monotonic increase in risk for chloroform.
Increased risks of SGA were observed for
TTHM > 40 µg/L, chloroform > 20 µg/L,
BDCM > 5 µg/L, and mutagenic activity
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Table 3. The effect of third-trimester DBP and mutagenicity exposure on mean birth weight among term
births and gestational age among all births.a
Birth weight Gestational age
No. of ∆ Birth No. of ∆ Gestational
Exposure birthsb weight (g)b 95% CI births age (days) 95% CI
THMs (µg/L)
TTHM
0–33 89,881 Reference 95,630 Reference
> 33–74 70,567 –12 –16 to –7 74,956 0.0 –0.1 to 0.1
> 74–163 16,729 –18 –26 to –10 17,627 0.5 0.3 to 0.7
Per 66 µg/L –18 –23 to –13 0.3 0.1 to 0.4
Chloroform
0–26 91,277 Reference 97,040 Reference
> 26–63 69,285 –14 –19 to –9 73,637 0.0 –0.2 to 0.1
> 63–135 16,153 –18 –26 to –10 17,054 0.4 0.2 to 0.6
Per 59 µg/L –19 –25 to –14 0.1 0.0 to 0.3
BDCM
0–5 101,564 Reference 108,457 Reference
> 5–13 60,873 –12 –17 to –8 64,215 0.6 0.5 to 0.7
> 13–46 14,278 –12 –20 to –3 15,059 0.5 0.3 to 0.8
Per 11 µg/L –9 –13 to –4 0.5 0.4 to 0.6
HAAs (µg/L)c
Total HAA
4–30 7,853 Reference 8,360 Reference
> 30–49 6,599 25 9 to 40 7,005 0.1 –0.3 to 0.5
> 49–58 881 7 –25 to 39 934 0.7 –1.5 to 0.1
Per 36 µg/L 25 6 to 45 0.2 –0.2 to 0.6
Trichloroacetic acid
0–18 5,175 Reference 5,494 Reference
> 18–27 4,953 21 3 to 39 5,264 0.2 –0.3 to 0.6
> 27–37 1,031 –4 –35 to 27 1,093 –0.9 –1.7 to –0.1
Per 19 µg/L 16 –9 to 40 0.1 –0.6 to 0.8
Dichloroacetic acid
2–15 5,135 Reference 5,457 Reference
> 15–22 4,346 15 –4 to 34 4,587 0.0 –0.5 to 0.5
> 22–24 1,678 12 –14 to 38 1,807 –0.3 –0.9 to 0.4
Per 16 µg/L 29 4 to 55 0.1 –0.4 to 0.6
MX (ng/L)c
4–20 7,368 Reference 7,804 Reference
> 20–46 5,542 –2 –17 to 14 5,879 –0.4 –0.8 to 0.0
> 46–80 1,484 –18 –44 to 8 1,552 0.1 –0.5 to 0.8
Per 32 ng/L –14 –33 to 5 0.2 –0.3 to 0.7
Mutagenicity (rev/L)c
330–1,250 6,414 Reference 6,763 Reference
> 1,250–2,250 6,476 –19 –35 to –2 6,909 –0.5 –0.9 to 0.0
> 2,250–5,710 1,504 –27 –54 to –1 1,563 1.1 0.4 to 1.7
Per 1,450 rev/L –16 –32 to –1 0.5 0.1 to 0.9
aRegression coefficients adjusted for median household income, infant sex, adequacy of prenatal care, maternal race,
maternal education, maternal cigarette consumption, maternal age, parity, previous infant weighing ≥ 4,000 g, previous
preterm delivery, and maternal medical history (diabetes, chronic hypertension, lung disease, and renal disease). bAmong
term births only. c1997–1998 analyses included adjustment for marital status and weight gain during pregnancy.
Figure 1. Change in mean birth weight and 95% CIs
for third-trimester THM exposures: regression coefﬁ-
cients for (A) TTHM, (B) chloroform, and (C) BDCM
adjusted for median household income, infant sex,
adequacy of prenatal care, maternal race, maternal
education, maternal cigarette consumption, maternal
age, parity, previous infant weighing ≥ 4,000 g, previ-
ous preterm delivery, and maternal medical history
(diabetes, chronic hypertension, lung disease, and
renal disease).
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Concentration (µg/L)> 2,250 rev/L. The effects of DBPs and muta-
genicity on SGA and birth weight were
smaller than previously reported for THMs.
Elevated TTHM and chloroform exposures
were associated with a reduced risk of preterm
delivery (< 37 gestational weeks). We found
similar reductions in the risk of very preterm
delivery (< 34 gestational weeks), although an
increased risk was detected for total HAAs and
trichloroacetic acid. It is unclear whether these
differences are due to less misclassification
among very preterm infants than among
preterm infants or result from inaccurate gesta-
tional age estimates. We confirmed previous
findings of associations between high THM
exposures and increases in mean gestational age
(Wright et al. 2003), but we are cautious in our
interpretation given the likelihood of errors in
gestational age estimates (David 1980; Gjessing
et al. 1999). Although the clinical signiﬁcance
of small changes in gestational duration and
birth weight is unclear, the potential public
health impact is considerable given widespread
exposure to DBPs.
The modest effects that were detected
reinforce the need for adequate control of
confounding in environmental epidemiologic
studies. Because of the comprehensive birth
certiﬁcate data in Massachusetts, we were able
to adjust for many potential confounders pre-
viously not considered. Moreover, nonpara-
metric smoothing of confounders allowed for
better control of established maternal risk fac-
tors for fetal growth retardation. Gestational
age was a strong predictor of birth weight, but
it is unclear whether gestational age is an
intermediate in the causal pathway of DBPs
and birth weight. Because bias may be intro-
duced by adjusting for a causal intermediate
(Rothman and Greenland 1998), we did not
include gestational age in the ﬁnal regression
models. We had similar concerns regarding
several maternal medical conditions including
eclampsia, hydramnios, hypertension during
pregnancy, and uterine bleeding, despite their
being strong risk factors for infant birth
weight. Adjustment for these covariates had
minimal effect on the results, so they were not
included in the ﬁnal regression models.
The main limitation of our study is the
potential for exposure misclassification,
because we relied on town average data to
estimate individual exposures. Although we
were unable to assess within-town variability
because of the use of the aggregate exposure
measures, between-town variability accounts
for most of the total variation in DBP concen-
trations (Keegan et al. 2001). Interindividual
variability in water use (e.g., showering, water
consumption) is an important determinant of
overall DBP exposure. Incorporating individ-
ual information such as water consumption
rates should limit the amount of exposure
misclassification, but previous studies have
reported equivocal findings compared with
the use of town average exposure measures
(Klotz and Pyrch 1999; Savitz et al. 1995;
Waller et al. 1998). The lack of information
on maternal water use limited our ability to
assess the impact of speciﬁc routes of exposure.
Although inhalation and dermal absorption
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Figure 2. ORs and 95% CIs for SGA infancy and
third-trimester THM exposures: ORs for (A) TTHM,
(B) chloroform, and (C) BDCM adjusted for median
household income, adequacy of prenatal care,
maternal race, maternal education, maternal smok-
ing, maternal age, parity, previous infant weighing
≥ 4,000 g, previous preterm delivery, and maternal
medical history (diabetes, chronic hypertension,
lung disease, and renal disease).
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Table 4. Adjusted ORs and 95% CIs for SGA and preterm delivery by third-trimester DBP and mutagenicity
exposure.a
SGAb,c Preterm deliveryd
Exposure OR (95% CI) OR (95% CI)
THMs (µg/L)
TTHM
0–33 1.0 1.0
> 33–74 1.06 (1.02 to 1.10) 0.95 (0.91 to 0.99)
> 74–163 1.13 (1.07 to 1.20) 0.88 (0.81 to 0.94)
Chloroform
0–26 1.0 1.0
> 26–63 1.05 (1.02 to 1.09) 0.95 (0.91 to 0.99)
> 63–135 1.11 (1.04 to 1.17) 0.90 (0.84 to 0.97)
BDCM
0–5 1.0 1.0
> 5–13 1.1 (1.07 to 1.14) 0.89 (0.85 to 0.93)
> 13–46 1.15 (1.08 to 1.22) 0.92 (0.85 to 0.99)
HAAs (µg/L)e
Total HAAs
4–30 1.0 1.0
> 30–49 0.90 (0.81 to 1.01) 0.95 (0.83 to 1.10)
> 49–58 0.97 (0.77 to 1.23) 1.03 (0.77 to 1.39)
Trichloroacetic acid
0–18 1.0 1.0
> 18–27 0.87 (0.76 to 0.99) 0.91 (0.77 to 1.07)
> 27–37 0.95 (0.76 to 1.19) 1.07 (0.81 to 1.42)
Dichloroacetic acid
2–15 1.0 1.0
> 15–22 0.86 (0.75 to 0.99) 0.85 (0.71 to 1.01)
> 22–24 0.90 (0.75 to 1.09) 0.99 (0.79 to 1.23)
MX (ng/L)e
4–20 1.0 1.0
> 20–46 0.97 (0.86 to 1.09) 1.03 (0.89 to 1.19)
> 46–80 1.14 (0.95 to 1.37) 0.87 (0.66 to 1.14)
Mutagenicity (rev/L)e
330–1,250 1.0 1.0
> 1,250–2,250 0.98 (0.87 to 1.11) 1.09 (0.94 to 1.27)
> 2,250–5,710 1.25 (1.04 to 1.51) 0.79 (0.59 to 1.05)
aORs adjusted for median household income, adequacy of prenatal care, maternal race, maternal education, maternal
smoking, maternal age, parity, previous infant weighing ≥ 4,000 g, previous preterm delivery, and maternal medical history
(diabetes, chronic hypertension, lung disease, and renal disease). bSGA deﬁned as lowest 10% of birth weight per gesta-
tional age, sex, and race. cAmong term births only. dPreterm (< 37 gestational weeks) analyses adjusted for infant sex.
e1997–1998 analyses adjusted for marital status and weight gain during pregnancy.are important determinants of exposure to
volatile DBPs such as THMs (Weisel and Jo
1996), mothers exposed to high THM levels
via drinking water also likely receive high
exposures from other routes. The contribution
of dermal and inhalation exposures to overall
dose is considered minimal for nonvolatile
DBPs such as HAAs and MX (Xu et al. 2002).
Residential mobility can lead to additional
misclassiﬁcation of exposures that are based on
maternal ZIP codes at time of birth. Although
an estimated 20–25% of women move during
pregnancy (Khoury et al. 1988; Shaw and
Malcoe 1992; Speare et al. 1976), only 8% of
mothers of infants with birth defects reported
moving to a different county during pregnancy
(Khoury et al. 1988). Klotz and Pyrch (1999)
conducted a sensitivity analysis addressing the
impact of residential mobility on risk of neural
tube defects for DBP exposures during the ﬁrst
month of pregnancy. Slightly stronger asso-
ciations were detected among mothers with
known residences at conception compared with
those with confirmed and unconfirmed resi-
dences. The impact of mobility may depend on
the critical period of exposure, because women
may be less likely to move late in pregnancy.
Among women who moved during pregnancy,
Schulman et al. (1993) reported that 40% chose
to move during the ﬁrst trimester. This suggests
that misclassiﬁcation due to residential mobility
is less likely to inﬂuence third-trimester expo-
sure estimates. Although exposure misclassiﬁca-
tion is present to some degree in our study,
these errors are unlikely to be associated with
the birth outcomes. Random exposure misclas-
sification will typically bias effect estimates
toward the null and may explain the modest
effects that we observed.
TTHM concentration may be of limited
value as a surrogate of DBP exposure because
the degree of correlation with individual THMs
and nonvolatile DBPs can vary dramatically by
water system (King et al. 2000; Whitaker et al.
2003; Wright et al. 2002). We observed effects
similar in magnitude for individual THMs such
as chloroform and BDCM, although most of
the water systems in our study had low levels of
brominated THMs. The associations that we
detected between mutagenicity with birth
weight and risk of small for gestational age
infancy suggest an effect of mutagenic com-
pounds on fetal development. These associa-
tions are not likely attributable to HAAs or
THMs, because these DBPs are not considered
strong mutagens (Daniel et al. 1993; Rosenthal
1987). MX was strongly correlated with muta-
genic activity (r = 0.86) in drinking water
samples from Massachusetts (Wright et al.
2002), but adjustment for MX in the regression
models did not substantially alter the effect of
mutagenic activity on mean birth weight (data
not shown). Mutagenicity may be a better indi-
cator of the complex mixture of mutagenic
compounds present in drinking water than are
traditional DBP surrogates, but additional
research is needed to determine the correlation
between mutagenicity and individual DBP
concentrations.
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